Glucose metabolism in chronic lung disease

H.P. Sauerwein*, A.M.W.J. Schols

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Glucose metabolism in chronic lung disease.

Sauerwein HP, Schols AM.

Department of Endocrinology and Metabolism, Academic Medical Center, Amsterdam, The Netherlands.

Chronic disease in general induces insulin resistance on glucose metabolism on hepatic and peripheral levels. Hypoxia in healthy subjects, induced by chronic altitude exposure, stimulates glucose production with decreased hepatic insulin sensitivity, but increases peripheral insulin sensitivity. Chronic obstructive lung disease (COPD) is a chronic inflammatory disease characterised by chronic or intermittent hypoxia. Therefore theoretically, COPD can be a chronic disease with unique features in peripheral insulin sensitivity. In this literature review the available data on glucose metabolism in COPD and cystic fibrosis are discussed in relation to this potential unique feature of increased peripheral insulin sensitivity despite the existence of chronic disease. The scarce data do not refute this possibility, but better studies aimed at exploring the influence of the degree of hypoxia on peripheral insulin sensitivity in chronic lung disease are necessary to unravel the role of oxygen in the regulation of peripheral glucose metabolism
Original languageEnglish
Pages (from-to)367-371
Number of pages3
JournalClinical Nutrition
Issue number5
Publication statusPublished - 1 Jan 2002


Dive into the research topics of 'Glucose metabolism in chronic lung disease'. Together they form a unique fingerprint.

Cite this